About Acuamark Diagnostics

About company

Acuamark Diagnostics develops technology that allows for a highly accurate screening of blood to detect cancer markers at the early cancer stages before cancer becomes untreatable. Backed by a highly experienced team of scientific and business professionals, it is its mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection. It was founded in 2012 and is headquartered in New York, New York.